XML 78 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Collaboration Revenue [Member] Collaboration Revenue [Member] Collaboration Revenue [Member]
Collaboration revenue $ 17,157,000 $ 10,287,000 $ 63,175,000
Operating expenses:      
Research and development 132,283,000 88,798,000 98,496,000
General and administrative 41,946,000 36,643,000 21,493,000
Acquired in-process research and development 7,339,000 0 0
Total operating expenses 181,568,000 125,441,000 119,989,000
Loss from operations (164,411,000) (115,154,000) (56,814,000)
Other income (expense), net:      
Interest income 18,873,000 7,550,000 431,000
Non-cash interest expense for the sale of future royalties (18,083,000) (21,108,000) (1,450,000)
Other (expense) income, net (2,000) 12,000 37,000
Total other income (expense), net 788,000 (13,546,000) (982,000)
Loss before income taxes (163,623,000) (128,700,000) (57,796,000)
Benefit (Provision) for income taxes 4,000 (24,000) 0
Net loss (163,619,000) (128,724,000) (57,796,000)
Other comprehensive loss:      
Unrealized gain (loss) on available for sale securities 4,449,000 (4,824,000) (418,000)
Comprehensive loss $ (159,170,000) $ (133,548,000) $ (58,214,000)
Net loss per common share:      
Basic (in dollars per share) $ (6.08) $ (4.57) $ (2.11)
Diluted (in dollars per share) $ (6.08) $ (4.57) $ (2.11)
Weighted-average number of shares outstanding:      
Basic (in shares) 26,924 28,165 27,431
Diluted (in shares) 26,924 28,165 27,431